| Antidiabetic drug |
Cases of Bladder Cancer |
Total Number |
Odds
ratio |
95% CI |
P |
| Pioglitazone |
15 |
720 |
1.37 |
0.55-3.42 |
0.4958 |
| Glucagon-like peptide-1 analog |
0 |
7 |
NA |
NA |
NA |
| Dipeptidyl peptidase-4 inhibitor |
5 |
279 |
1.43 |
0.44-3.88 |
0.5249 |
| Alpha-glucosidase inhibitor(AGI) |
9 |
623 |
0.74 |
0.29-1.80 |
0.5096 |
| Biguanides |
5 |
606 |
0.43 |
0.13-1.20 |
0.1094 |
| Prandial Glucose regulators |
4 |
200 |
1.41 |
0.39-4.06 |
0.572 |
| Sulphonylureas (Second generation) |
6 |
238 |
2 |
0.76-4.95 |
0.1531 |
| Sulphonylureas (Third generation) |
8 |
376 |
2.05 |
0.70-5.32 |
0.1788 |
| Insulin |
10 |
437 |
2.83 |
1.15-6.84 |
0.0246* |
